KISQALI

Kisqali is the brand name for the medication ribociclib. It is a prescription medicine used in combination with other drugs to treat a specific type of breast cancer called hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) advanced or metastatic breast cancer. Ribociclib belongs to a class of drugs known as cyclin-dependent kinase 4/6 (CDK4/6) inhibitors. CDK4/6 is a protein that plays a role in cell division and growth, and by inhibiting its activity, ribociclib helps slow down the growth and division of cancer cells. .